Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that can involve virtually all organ systems. Whereas most patients present without symptoms, progressive and disabling organ failure can occur in up to 10% of subjects. Somatostatin receptor (SSTR)-directed peptide receptor radionuclide therapy (PRRT) has recently received market authorization for treatment of SSTR-positive neuroendocrine tumors.

中文翻译：

---

肽受体放射性核素疗法作为治疗难治性结节病的新工具-两名患者的初步经验

结节病是一种病因不明的多系统肉芽肿性疾病，实际上可能涉及所有器官系统。尽管大多数患者都没有症状，但最多有10％的受试者会发生进行性和致残性器官衰竭。生长抑素受体（SSTR）指导的肽受体放射性核素治疗（PRRT）最近已获得市场认可，可用于治疗SSTR阳性的神经内分泌肿瘤。